Tofogliflozin GLP-1 Analogue Combination Trial
Phase 4
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Kowa Company, Ltd.
- Target Recruit Count
- 65
- Registration Number
- NCT02537834
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Phase 3
Completed
- Conditions
- Hepatic Neoplasm Malignant Recurrent
- Interventions
- Drug: PlaceboDrug: NIK-333(peretinoin)
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Kowa Company, Ltd.
- Target Recruit Count
- 616
- Registration Number
- NCT01640808